Category Archives: General HIV+ population
Reviews on HIV+ people where the population is not specified
How do migrants living with HIV adhere to the HIV care process in high-income countries? A systematic review
BACKGROUND: In high-income countries (HICs), migrants living with HIV (MLHIV) are more likely than other HIV subpopulations to encounter problems which hamper their adherence to the care process; these include...
Studies on cognitive performance among older people living with HIV in eastern Europe and central Asia: A scoping review
BACKGROUND: Despite the growth of the population of older people living with HIV (PLWH), data on cognitive disorders among older PLWH, particularly in low- and middle-income countries, are scarce. These...
Sensory neuropathy and associated factors among patients living with human immuno-deficiency virus in Africa: A systematic review and meta-analysis
Introduction Despite high prevalence of sensory neuropathy among individuals living with HIV, there is no comprehensive information regarding variables that determine sensory neuropathy onset among the patients who attended health...
Characterization and stratification of risk factors of stroke in people living with HIV: A theory-informed systematic review
Background Identification and stratification of risk factors for stroke among individuals living with HIV (PLWH) will facilitate primary prevention and prognostication, as well as strategies aimed at optimizing neurorehabilitation. This...
The global prevalence of an factors associated with parasitic coinfection in people living with viruses: A systematic review and meta-analysis
Coinfection with parasites and viruses can exacerbate disease transmission, outcomes and therapy. This study searched the Web of Science, PubMed, Scopus and JSTOR databases for publications on the prevalence of...
What services, interventions and support are available for people with HIV in England to manage their overall health and wellbeing? A scoping review
OBJECTIVES: The average age of a person living with HIV in high-income countries is increasing, as are rates of multimorbidity and frailty. To meet these needs, existing services must adapt....
Ambivalent experiences of people in treatment for tuberculosis-HIV coinfection: A meta-synthesis of qualitative studies
This study examined the scientific literature, by means of a systematic review with meta-synthesis (PROSPERO No. CRD42023410141), to discover the experiences of people undergoing treatment for tuberculosis-HIV coinfection. Ten databases...
Interventions to improve HIV care continuum outcomes for people with HIV who have incarceration experience: A narrative review
People with HIV who are reentering the community after incarceration encounter multiple barriers to engagement in HIV care and treatment. We conducted a narrative review of recent interventions (2020-2023) developed...
A systematic review of prolonged SARS-CoV-2 shedding in immunocompromised persons
Background Although reports have documented prolonged SARS‐CoV‐2 RNA detection in immunocompromised patients, few studies have systematically analyzed data on duration of SARS‐CoV‐2 in respiratory specimens of immunocompromised patients. Methods A...
Systematic review exploring the burden of sexually transmissible infections and bloodborne viruses in refugees and asylum seekers: Insights to inform policy and practice
BACKGROUND: In 2022, the number of refugees and asylum seekers (RAS) have reached an all-time high of 40.7 million globally. The surge in RAS, coupled with their limited access to...
Effects of test-and-treat versus preexposure prophylaxis on elimination of HIV transmission: Analysis of 24 HIV prevention trials
INTRODUCTION: In 2023, 28.8 million (72%) of 39.9 million people with HIV (PWH) worldwide were on treatment with viral suppression, while 11.1 million (28%) people had viraemia with the risk...
Mapping the gut microbiota composition in the context of Raltegravir, dolutegravir, and bictegravir—A scoping review
(1) Background: Second-generation integrase strand transfer inhibitors (INSTIs) are now the preferred first-line therapies for human immunodeficiency virus (HIV). However, concerns regarding their side effects, such as weight gain and...
